Literature DB >> 2293867

Computed tomographic findings of nasopharyngeal carcinoma with skull base and intracranial involvement.

T Miura1, N Hirabuki, K Nishiyama, T Hashimoto, R Kawai, J Yoshida, R Sasaki, T Matsunaga, T Kozuka.   

Abstract

Twenty-nine patients with nasopharyngeal carcinoma (NPC) with skull base or intracranial involvement were analyzed by high-resolution computed tomography (CT). We divided the path of the primary tumor spread into six directions from the nasopharynx. The most common direction of spread was the anterior region, and the second most common was the posterolateral region. Recently, high resolution CT has been used for the diagnosis of the nasopharynx. T-staging of NPC was made according to the International Union Against Cancer (UICC) TNM classification system, depending on clinical findings and conventional radiograph examinations (not including CT). CT images were valuable for detection of the primary tumor involvement of the skull base region in NPC. Furthermore, bone target CT images were better for searching for subtle bony changes. Therefore, we recommend that CT should be used in T-staging of NPC systematically. When CT is used as one of the staging criteria, some patients with NPC with subtle bony changes will be upstaged.

Entities:  

Mesh:

Year:  1990        PMID: 2293867     DOI: 10.1002/1097-0142(19900101)65:1<29::aid-cncr2820650109>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Assessment of skull base involvement in nasopharyngeal carcinoma: comparisons of single-photon emission tomography with planar bone scintigraphy and X-ray computed tomography.

Authors:  C H Lee; P W Wang; H Y Chen; C C Lui; C Y Su
Journal:  Eur J Nucl Med       Date:  1995-06

2.  A new T staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results from a prospective multicentric clinical study.

Authors:  Min Kang; Pingting Zhou; Tingting Wei; Tingting Zhao; Jianxiong Long; Guisheng Li; Haolin Yan; Guosheng Feng; Meilian Liu; Jinxian Zhu; Rensheng Wang
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.